Tau enhances α-synuclein aggregation and toxicity in cellular models of synucleinopathy.
about
α-Synuclein modifies huntingtin aggregation in living cellsLRRK2 interactions with α-synuclein in Parkinson's disease brains and in cell modelsCerebrospinal Fluid Amyloid β1-42, Tau, and Alpha-Synuclein Predict the Heterogeneous Progression of Cognitive Dysfunction in Parkinson's DiseaseChronic traumatic encephalopathy: a spectrum of neuropathological changes following repetitive brain trauma in athletes and military personnelAlpha-synuclein and tau: teammates in neurodegeneration?Roles of tau protein in health and disease.Intranasal NAP (davunetide) decreases tau hyperphosphorylation and moderately improves behavioral deficits in mice overexpressing α-synuclein.A powerful yeast model to investigate the synergistic interaction of α-synuclein and tau in neurodegeneration.α-Synuclein modifies mutant huntingtin aggregation and neurotoxicity in Drosophila.A First Tetraplex Assay for the Simultaneous Quantification of Total α-Synuclein, Tau, β-Amyloid42 and DJ-1 in Human Cerebrospinal FluidCSF Biomarkers and Its Associations with 18F-AV133 Cerebral VMAT2 Binding in Parkinson's Disease-A Preliminary Report.Acute administration of L-DOPA induces changes in methylation metabolites, reduced protein phosphatase 2A methylation, and hyperphosphorylation of Tau protein in mouse brain.Immunotherapeutic Approaches Targeting Amyloid-β, α-Synuclein, and Tau for the Treatment of Neurodegenerative Disorders.Co-immunoprecipitation with Tau Isoform-specific Antibodies Reveals Distinct Protein Interactions and Highlights a Putative Role for 2N Tau in Disease.The effect of MAPT haplotype on neocortical Lewy body pathology in Parkinson disease.α-Synuclein in cerebrospinal fluid of Alzheimer's disease and mild cognitive impairmentCSF α-synuclein improves diagnostic and prognostic performance of CSF tau and Aβ in Alzheimer's diseaseAV-1451 tau and β-amyloid positron emission tomography imaging in dementia with Lewy bodies.Interaction between pathogenic proteins in neurodegenerative disorders.Intrinsically disordered proteins: from sequence and conformational properties toward drug discovery.Examining the mechanisms that link β-amyloid and α-synuclein pathologies.FRET and FRAP imaging: approaches to characterise tau and stathmin interactions with microtubules in cells.Neuropathology of multiple system atrophy: new thoughts about pathogenesis.Protein Transmission, Seeding and Degradation: Key Steps for α-Synuclein Prion-Like PropagationConfluence of α-synuclein, tau, and β-amyloid pathologies in dementia with Lewy bodies.Dementia With Lew Body: Impacts of Surgery.Review: The spectrum of clinical features seen with alpha synuclein pathology.α-Synuclein Aggregates with β-Amyloid or Tau in Human Red Blood Cells: Correlation with Antioxidant Capability and Physical Exercise in Human Healthy Subjects.Interactions Between α-Synuclein and Tau Protein: Implications to Neurodegenerative Disorders.DJ-1 interactions with α-synuclein attenuate aggregation and cellular toxicity in models of Parkinson's disease.Oxidative stress promotes uptake, accumulation, and oligomerization of extracellular α-synuclein in oligodendrocytes.New α- and γ-synuclein immunopathological lesions in human brain.Mutant huntingtin alters Tau phosphorylation and subcellular distribution.MultiTEP platform-based DNA vaccines for alpha-synucleinopathies: preclinical evaluation of immunogenicity and therapeutic potency.A Focus on the Beneficial Effects of Alpha Synuclein and a Re-appraisal of Synucleinopathies.The limbic and neocortical contribution of α-synuclein, tau, and amyloid β to disease duration in dementia with Lewy bodies.Concomitant accumulation of α-synuclein and TDP-43 in a patient with corticobasal degeneration.α-Synuclein Aggregated with Tau and β-Amyloid in Human Platelets from Healthy Subjects: Correlation with Physical Exercise.Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.Regional Overlap of Pathologies in Lewy Body Disorders.
P2860
Q24298430-54AF7DA9-A33E-4D5C-A500-1620017ED7BEQ24304959-9A55599C-97C2-4406-BBA1-E2400D651E99Q26744782-AF9EA651-3405-47A1-8643-3E256B64B1A5Q27001265-AA1CA2CE-27BA-4E16-8E07-778E514CBEB5Q28250508-77D8BEAB-3658-492A-AC72-69B590BC5338Q33559303-471FE482-0183-4D42-B14C-1D76212CF6A4Q34292532-06CDBDE6-E191-4873-A2EC-316C1C36C1B8Q34581042-CA07F288-9ADC-444B-93A3-3C28E7AF5A0FQ35163459-01A2BBDE-6994-4FB8-89DD-76F775550A78Q35999591-F44D0F18-2E2C-48C1-AD3D-19DFF65F7602Q36169215-6D2804A0-D5AB-4E88-B95C-CBAFF9809A8EQ36174698-F0AA34C4-6C5B-48DB-BC63-EF0EA4ED4231Q36484413-2B442621-B91E-46C1-85C0-C83CBAF9DF6AQ36778845-6C4AE5D1-31D8-4A7E-923C-1426BEA97616Q37082285-4A473CB3-D566-4CA9-B77E-B8F20A33C5D4Q37086400-0D7CEA3A-BEC6-40BB-8F4C-F8A4C87733BDQ37266166-24CE41AD-FB69-48D4-9635-ADAB222F2AEBQ37633577-5B4DE0F1-FEE4-4762-A3A1-D1BEAA2E35B7Q37969262-DC2A33C2-AC26-4FFC-8623-57A80FB1AB1BQ38002804-D52666B7-6559-4151-A708-CD7C109C6650Q38006559-750463B5-A430-401F-8C04-1AF8455F6E54Q38073336-DEC84DC4-9A51-4BC5-AFE9-C825CDEDBD3BQ38258246-2583EFCA-5BC1-4B3C-9866-1CB7DD3D1D01Q38303579-CFAEE925-11CF-4DC9-A164-1FDC5116039DQ38311234-A62999C3-CB07-407D-9420-760FD571BF82Q38501488-D1E97257-7CB0-4E4F-889A-A4CA053185FFQ38691823-9F09DC3F-9C5A-4939-9EA0-AC38306AAEE5Q38831103-FA6D1B42-A29F-4F80-A6E7-A19A47C724D1Q38954686-4A6550A9-EDA5-4573-A61B-6523DD823F0DQ38972171-A70792CF-E578-44CF-B0F7-6CA2D7DD6CA6Q39064365-2FEA862D-C4E0-46D6-A1C6-A7C09C760192Q42062219-C8FCD218-DE07-4B66-B2FE-54DA9E5E6A2AQ45301226-F2830565-E6D3-42E5-B8D5-4E9B01EE4571Q45304017-14C75981-9F40-478E-B68B-7F1C0AD0FDDEQ47389795-75FEB59F-0A05-4203-AD1E-331FE2B9FBB6Q47666324-59B859E1-8A09-43B8-A49A-89930EA93681Q48550467-4686BA7B-8EA8-4C92-B64E-9EE7BD85C905Q49240647-7231BE6D-BA35-4120-BE21-C771EB41FD6BQ49987358-FCEA356E-973E-46B3-90AF-A4D48214DDF6Q50211142-6E63A1BF-85D4-463E-B868-3725A9A0D01E
P2860
Tau enhances α-synuclein aggregation and toxicity in cellular models of synucleinopathy.
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Tau enhances α-synuclein aggregation and toxicity in cellular models of synucleinopathy.
@ast
Tau enhances α-synuclein aggregation and toxicity in cellular models of synucleinopathy.
@en
Tau enhances α-synuclein aggregation and toxicity in cellular models of synucleinopathy.
@nl
type
label
Tau enhances α-synuclein aggregation and toxicity in cellular models of synucleinopathy.
@ast
Tau enhances α-synuclein aggregation and toxicity in cellular models of synucleinopathy.
@en
Tau enhances α-synuclein aggregation and toxicity in cellular models of synucleinopathy.
@nl
prefLabel
Tau enhances α-synuclein aggregation and toxicity in cellular models of synucleinopathy.
@ast
Tau enhances α-synuclein aggregation and toxicity in cellular models of synucleinopathy.
@en
Tau enhances α-synuclein aggregation and toxicity in cellular models of synucleinopathy.
@nl
P2093
P2860
P50
P1433
P1476
Tau enhances α-synuclein aggregation and toxicity in cellular models of synucleinopathy.
@en
P2093
Alberto Lleó
Jordi Clarimon
Tiago Fleming Outeiro
P2860
P304
P356
10.1371/JOURNAL.PONE.0026609
P407
P50
P577
2011-10-24T00:00:00Z